My Quote Request
No products added yet
6505-01-194-0379
20 Products
NDC00585-0673-03
CROMOLYN SODIUM INHALATION SOLUTION,USP
NSN, MFG P/N
6505011940379
NSN
6505-01-194-0379
NDC00585-0673-03
CROMOLYN SODIUM INHALATION SOLUTION,USP
NSN, MFG P/N
6505011940379
NSN
6505-01-194-0379
MFG
FISONS CORP PRESCRIPTION DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CROMOLYN SODIUM PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CROMOLYN SODIUM INHALATION SOL USP 10MG/ML 2ML AMPUL 120S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 120
Related Searches:
NDC11098-0050-05
SUFENTANIL CITRATE INJECTION
NSN, MFG P/N
6505011932690
NSN
6505-01-193-2690
NDC11098-0050-05
SUFENTANIL CITRATE INJECTION
NSN, MFG P/N
6505011932690
NSN
6505-01-193-2690
MFG
AKORN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT OF 50 MICROGRAMS PER MILLILITER SUFENTINAL BASE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUFENTANIL CITRATE INJECTION 5ML AMPUL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00524-0062-01
IBUPROFEN TABLETS,USP
NSN, MFG P/N
6505011932828
NSN
6505-01-193-2828
NDC00524-0062-01
IBUPROFEN TABLETS,USP
NSN, MFG P/N
6505011932828
NSN
6505-01-193-2828
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS IBUPROFEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
RUFEN
IBUPROFEN TABLETS,USP
NSN, MFG P/N
6505011932828
NSN
6505-01-193-2828
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS IBUPROFEN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ANGIOVIST 292
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505011932829
NSN
6505-01-193-2829
ANGIOVIST 292
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505011932829
NSN
6505-01-193-2829
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT AND 8.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 292.500 MILLIGRAMS IODINE, PROTEIN-BOUND PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH PLASTIC HANGING DEVICE
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
NDC50419-0191-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505011932829
NSN
6505-01-193-2829
NDC50419-0191-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505011932829
NSN
6505-01-193-2829
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT AND 8.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 292.500 MILLIGRAMS IODINE, PROTEIN-BOUND PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH PLASTIC HANGING DEVICE
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
NDC00054-3805-63
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011932830
NSN
6505-01-193-2830
NDC00054-3805-63
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011932830
NSN
6505-01-193-2830
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 GRAMS SODIUM POLYSTYRENE SULFONATE PER MILLILITER
ADMINISTRATION: ORAL OR RECTAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM POLYSTYRENE SULFONATE SUSPENSION USP 500ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; NOTE: F
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: EACH 60 ML CONTAINS 15 GRAMS SODIUM POLYSTYRENE SULFONATE,17-21.5 ML SORBITOL SOLUTION,0.2-0.3% ALCOHOL,AND 1.5 GRAMS (65 MEQ) SODIUM; A PALATABLE,FLAVORED SODIUM POLYSTYRENE SULFONATE SUSPENSION
Related Searches:
NDC46287-0006-01
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011932830
NSN
6505-01-193-2830
NDC46287-0006-01
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011932830
NSN
6505-01-193-2830
MFG
CAROLINA MEDICAL PRODUCTS COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 GRAMS SODIUM POLYSTYRENE SULFONATE PER MILLILITER
ADMINISTRATION: ORAL OR RECTAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM POLYSTYRENE SULFONATE SUSPENSION USP 500ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; NOTE: F
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: EACH 60 ML CONTAINS 15 GRAMS SODIUM POLYSTYRENE SULFONATE,17-21.5 ML SORBITOL SOLUTION,0.2-0.3% ALCOHOL,AND 1.5 GRAMS (65 MEQ) SODIUM; A PALATABLE,FLAVORED SODIUM POLYSTYRENE SULFONATE SUSPENSION
Related Searches:
E-MYCIN TABLETS
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505011933547
NSN
6505-01-193-3547
E-MYCIN TABLETS
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505011933547
NSN
6505-01-193-3547
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED AND ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00009-0103-03
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505011933547
NSN
6505-01-193-3547
NDC00009-0103-03
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505011933547
NSN
6505-01-193-3547
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED AND ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00781-2699-01
CHLORPHENIRAMINE MALEATE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011934189
NSN
6505-01-193-4189
NDC00781-2699-01
CHLORPHENIRAMINE MALEATE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011934189
NSN
6505-01-193-4189
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;
Related Searches:
COLYTE
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
COLYTE
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
MFG
SCHWARZ PHARMA INC .
Description
EXTERIOR CONTAINER CUBIC MEASURE: 1.80 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 6
EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 274.310 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOTAL WEIGHT OF THE POWDER MAY VARY FROM 274 TO 279 GRAM; CONTAINS THE FOLLOWING ACTIVE INGREDIENTS FOR RECONSTITUTION TO AN ISOSMOTIC SOLUTION FOR ORAL ADMINISTRATION,236 TO 240 GRAM POLYETHYLENE GLYCOL 3350,2.9 TO 3 GRAM POTASSIUM CHLORIDE,6.7 TO 6.75
UNIT OF ISSUE CUBE: 0.30 CUBIC FEET
UNIT OF ISSUE WEIGHT: 1.33 POUNDS
~1: GRAM SODIUM BICARBONATE,5.8 TO 5.9 GRAM SODIUM CHLORIDE,21.7 TO 22.75 GRAM SODIUM SULFATE; MAY BE SUPPLIED IN DISPENSING BOTTLE OR IN ONE OR MORE PACKETS W/DISPENSING BOTTLE; FOR RECONSTITUTION TO 4 LITTERS IN BOTTLE W/ADDITIONAL SPACE FOR MIXING (MIN 48
~2: ML)
Related Searches:
GOLYTELY
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
GOLYTELY
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
MFG
BRAINTREE LABORATORIES INC.
Description
EXTERIOR CONTAINER CUBIC MEASURE: 1.80 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 6
EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 274.310 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOTAL WEIGHT OF THE POWDER MAY VARY FROM 274 TO 279 GRAM; CONTAINS THE FOLLOWING ACTIVE INGREDIENTS FOR RECONSTITUTION TO AN ISOSMOTIC SOLUTION FOR ORAL ADMINISTRATION,236 TO 240 GRAM POLYETHYLENE GLYCOL 3350,2.9 TO 3 GRAM POTASSIUM CHLORIDE,6.7 TO 6.75
UNIT OF ISSUE CUBE: 0.30 CUBIC FEET
UNIT OF ISSUE WEIGHT: 1.33 POUNDS
~1: GRAM SODIUM BICARBONATE,5.8 TO 5.9 GRAM SODIUM CHLORIDE,21.7 TO 22.75 GRAM SODIUM SULFATE; MAY BE SUPPLIED IN DISPENSING BOTTLE OR IN ONE OR MORE PACKETS W/DISPENSING BOTTLE; FOR RECONSTITUTION TO 4 LITTERS IN BOTTLE W/ADDITIONAL SPACE FOR MIXING (MIN 48
~2: ML)
Related Searches:
NDC00021-4401-23
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
NDC00021-4401-23
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
MFG
SCHWARZ PHARMA INC .
Description
EXTERIOR CONTAINER CUBIC MEASURE: 1.80 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 6
EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 274.310 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOTAL WEIGHT OF THE POWDER MAY VARY FROM 274 TO 279 GRAM; CONTAINS THE FOLLOWING ACTIVE INGREDIENTS FOR RECONSTITUTION TO AN ISOSMOTIC SOLUTION FOR ORAL ADMINISTRATION,236 TO 240 GRAM POLYETHYLENE GLYCOL 3350,2.9 TO 3 GRAM POTASSIUM CHLORIDE,6.7 TO 6.75
UNIT OF ISSUE CUBE: 0.30 CUBIC FEET
UNIT OF ISSUE WEIGHT: 1.33 POUNDS
~1: GRAM SODIUM BICARBONATE,5.8 TO 5.9 GRAM SODIUM CHLORIDE,21.7 TO 22.75 GRAM SODIUM SULFATE; MAY BE SUPPLIED IN DISPENSING BOTTLE OR IN ONE OR MORE PACKETS W/DISPENSING BOTTLE; FOR RECONSTITUTION TO 4 LITTERS IN BOTTLE W/ADDITIONAL SPACE FOR MIXING (MIN 48
~2: ML)
Related Searches:
NDC52268-0100-01
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
NDC52268-0100-01
POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
NSN, MFG P/N
6505011937331
NSN
6505-01-193-7331
MFG
BRAINTREE LABORATORIES INC.
Description
EXTERIOR CONTAINER CUBIC MEASURE: 1.80 CUBIC FEET
EXTERIOR CONTAINER QUANTITY: 6
EXTERIOR CONTAINER WEIGHT: 8.00 POUNDS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 274.310 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOTAL WEIGHT OF THE POWDER MAY VARY FROM 274 TO 279 GRAM; CONTAINS THE FOLLOWING ACTIVE INGREDIENTS FOR RECONSTITUTION TO AN ISOSMOTIC SOLUTION FOR ORAL ADMINISTRATION,236 TO 240 GRAM POLYETHYLENE GLYCOL 3350,2.9 TO 3 GRAM POTASSIUM CHLORIDE,6.7 TO 6.75
UNIT OF ISSUE CUBE: 0.30 CUBIC FEET
UNIT OF ISSUE WEIGHT: 1.33 POUNDS
~1: GRAM SODIUM BICARBONATE,5.8 TO 5.9 GRAM SODIUM CHLORIDE,21.7 TO 22.75 GRAM SODIUM SULFATE; MAY BE SUPPLIED IN DISPENSING BOTTLE OR IN ONE OR MORE PACKETS W/DISPENSING BOTTLE; FOR RECONSTITUTION TO 4 LITTERS IN BOTTLE W/ADDITIONAL SPACE FOR MIXING (MIN 48
~2: ML)
Related Searches:
101729
SOAP,SURGICAL
NSN, MFG P/N
6505011937363
NSN
6505-01-193-7363
MFG
HUNTINGTON LABORATORIES INC
Description
ABRASIVE ADDITIVE: NOT INCLUDED
LANOLIN FEATURE: INCLUDED
PHYSICAL FORM: LIQUID
QUANTITY WITHIN EACH UNIT PACKAGE: 1.000 GALLONS
SUPPLY PACKAGE TYPE: CASE
USAGE DESIGN: FRESH WATER
Related Searches:
NDC10563-0014-01
SOAP,SURGICAL
NSN, MFG P/N
6505011937363
NSN
6505-01-193-7363
MFG
HUNTINGTON LABORATORIES INC
Description
ABRASIVE ADDITIVE: NOT INCLUDED
LANOLIN FEATURE: INCLUDED
PHYSICAL FORM: LIQUID
QUANTITY WITHIN EACH UNIT PACKAGE: 1.000 GALLONS
SUPPLY PACKAGE TYPE: CASE
USAGE DESIGN: FRESH WATER
Related Searches:
NDC00054-3751-50
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505011938484
NSN
6505-01-193-8484
NDC00054-3751-50
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505011938484
NSN
6505-01-193-8484
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE ORAL SOLUTION 20MG/ML 120ML BOTTLE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ROXANE LABS INC
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, GLASS
Related Searches:
ROXANOL
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505011938484
NSN
6505-01-193-8484
ROXANOL
MORPHINE SULFATE ORAL SOLUTION
NSN, MFG P/N
6505011938484
NSN
6505-01-193-8484
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE ORAL SOLUTION 20MG/ML 120ML BOTTLE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ROXANE LABS INC
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, GLASS
Related Searches:
INTAL NEBULIZER SOLUTION
CROMOLYN SODIUM INHALATION SOLUTION,USP
NSN, MFG P/N
6505011940379
NSN
6505-01-194-0379
INTAL NEBULIZER SOLUTION
CROMOLYN SODIUM INHALATION SOLUTION,USP
NSN, MFG P/N
6505011940379
NSN
6505-01-194-0379
MFG
FISONS CORP PRESCRIPTION DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CROMOLYN SODIUM PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CROMOLYN SODIUM INHALATION SOL USP 10MG/ML 2ML AMPUL 120S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 120
